PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 58 filers reported holding PASSAGE BIO INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,175 | +416.7% | 9,385 | +639.6% | 0.00% | – |
| Q2 2023 | $1,195 | -99.8% | 1,269 | -99.8% | 0.00% | – |
| Q1 2023 | $564,000 | +69272.7% | 589,008 | 0.0% | 0.00% | – |
| Q4 2022 | $813 | -99.9% | 589,008 | -0.4% | 0.00% | – |
| Q3 2022 | $739,000 | -58.4% | 591,216 | -21.4% | 0.00% | – |
| Q2 2022 | $1,776,000 | -26.3% | 752,609 | -3.2% | 0.00% | – |
| Q1 2022 | $2,410,000 | -36.1% | 777,538 | +31.0% | 0.00% | – |
| Q4 2021 | $3,769,000 | -51.8% | 593,459 | -24.4% | 0.00% | -100.0% |
| Q3 2021 | $7,815,000 | -23.4% | 784,597 | +1.8% | 0.00% | 0.0% |
| Q2 2021 | $10,200,000 | +74.1% | 770,360 | +129.9% | 0.00% | 0.0% |
| Q1 2021 | $5,858,000 | +19.1% | 335,125 | +74.2% | 0.00% | 0.0% |
| Q4 2020 | $4,918,000 | +7351.5% | 192,345 | +3698.3% | 0.00% | – |
| Q3 2020 | $66,000 | -47.2% | 5,064 | +10.8% | 0.00% | – |
| Q2 2020 | $125,000 | – | 4,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |